The weekly litigation news digest is live. Subscribe now

IP Verse

Methods For Tissue Decellularization - EP2538988

The patent EP2538988 was granted to Decell on Jan 30, 2019. The application was filed on Feb 25, 2011 under application number EP11771666A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2538988

DECELL
Application Number
EP11771666A
Filing Date
Feb 25, 2011
Status
Opposition Rejected
Dec 10, 2021
Publication Date
Jan 30, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
TISSUE REGENIXOct 30, 2019HGFADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTCA2286655
INTERNATIONAL-SEARCH-REPORTCA2396698
INTERNATIONAL-SEARCH-REPORTGB2443938
INTERNATIONAL-SEARCH-REPORTUS2004076657
INTERNATIONAL-SEARCH-REPORTUS2008306610
OPPOSITIONGB2443938
OPPOSITIONUS2005013870
OPPOSITIONUS2008306610
OPPOSITIONUS5460962
SEARCHGB2443938
SEARCHUS2008306610
SEARCHUS6998418
SEARCHWO2006026325

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents